Xometry (NASDAQ:XMTR) CEO Sanjeev Singh Sahni Sells 1,500 Shares of Company Stock

Key Points

• Xometry CEO Sanjeev Sahni sold 1,500 shares at an average price of $108.80, generating $163,200. After the transaction, he retained 178,291 shares valued at approximately $19.4 million.
• Xometry shares recently traded at $95.15, down $12.75 for the day, though the stock remains near its 52-week high of $112.94. The company’s latest quarterly results exceeded expectations, with revenue rising 41.1% year over year to $229.28 million.
• Analysts maintain a generally positive outlook, with eight Buy, four Hold, and one Sell rating, producing a Moderate Buy consensus and an average price target of $113.18.

Xometry, Inc. (NASDAQ:XMTR - Get Free Report) CEO Sanjeev Sahni sold 1,500 shares of the stock in a transaction on Monday, October 12th. The shares were sold at an average price of $108.80, for a total value of $163,200.00. Following the sale, the chief executive officer owned 178,291 shares in the company, valued at approximately $19,398,060.80. This represents a 0.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Sanjeev Singh Sahni also recently made the following trade(s):

• On Friday, October 2nd, Sanjeev Sahni sold 1,112 shares of Xometry stock. The stock was sold at an average price of $103.28, for a total value of $114,847.36.
• On Monday, September 14th, Sanjeev Sahni sold 1,500 shares of Xometry stock. The stock was sold at an average price of $85.23, for a total value of $127,845.00.
• On Monday, August 17th, Sanjeev Sahni sold 1,500 shares of Xometry stock. The shares were sold at an average price of $90.19, for a total value of $135,285.00.

Xometry Stock Performance

Shares of Xometry stock traded down $12.75 during trading on Wednesday, hitting $95.15. 1,169,520 shares of the company's stock traded hands, compared to its average volume of 884,572. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.21 and a quick ratio of 3.20. Xometry, Inc. has a 1 year low of $35.86 and a 1 year high of $112.94. The stock has a market capitalization of $4.93 billion, a P/E ratio of -158.58 and a beta of 1.23. The business has a 50-day simple moving average of $95.23 and a 200-day simple moving average of $82.93.

Xometry (NASDAQ:XMTR - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.15 by $0.01. The company had revenue of $229.28 million during the quarter, compared to the consensus estimate of $215.22 million. Xometry had a negative return on equity of 2.88% and a negative net margin of 3.82%. Xometry's revenue for the quarter was up 41.1% on a year-over-year basis. During the same period last year, the company earned $0.09 EPS. As a group, analysts forecast that Xometry, Inc. will post -0.01 EPS for the current year.

Hedge Funds Weigh In On Xometry

Several large investors have recently made changes to their positions in XMTR. Integrated Wealth Concepts LLC purchased a new stake in shares of Xometry in the second quarter valued at about $36,000. GAMMA Investing LLC increased its stake in Xometry by 36.5% during the third quarter. GAMMA Investing LLC now owns 958 shares of the company's stock worth $99,000 after acquiring an additional 256 shares during the last quarter. CoreCap Advisors LLC acquired a new stake in Xometry during the second quarter worth $97,000. Nykredit A S purchased a new stake in Xometry in the second quarter valued at $103,000. Finally, PNC Financial Services Group Inc. raised its position in Xometry by 74.2% in the first quarter. PNC Financial Services Group Inc. now owns 1,636 shares of the company's stock valued at $67,000 after purchasing an additional 697 shares during the period. 97.31% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on XMTR shares. The Goldman Sachs Group lifted their target price on Xometry from $78.00 to $104.00 and gave the company a "neutral" rating in a research report on Wednesday, August 5th. Cantor Fitzgerald upped their price target on Xometry from $85.00 to $110.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 5th. Rosenblatt Securities raised their price objective on Xometry from $110.00 to $120.00 and gave the stock a "buy" rating in a research note on Tuesday, September 22nd. Citigroup reaffirmed a "market outperform" rating on shares of Xometry in a research note on Monday, September 21st. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Xometry in a research report on Wednesday, August 26th. Eight analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $113.18.

Xometry Company Profile

Xometry, Inc is a digital manufacturing marketplace that connects businesses with a network of manufacturing suppliers. Its platform uses software and artificial intelligence to help customers obtain quotes, place orders, and manage production for custom parts and components.

The company supports a range of manufacturing processes, including computer numerical control machining, 3D printing, sheet metal fabrication, injection molding, and related services. Xometry serves customers across industries such as aerospace and defense, automotive, industrial machinery, consumer products, and healthcare.

Founded in 2013, Xometry has expanded its marketplace and digital manufacturing services internationally, serving customers and suppliers in North America, Europe, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.